Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Solid Tumors, Neuroblastoma

John Maris

MD

🏢Children's Hospital of Philadelphia🌐USA

Giulio D'Angio Professor of Pediatrics

110
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

John Maris is a leading neuroblastoma genomics investigator who identified germline and somatic ALK mutations as tractable targets in high-risk disease. His laboratory has advanced targeted therapy and immunotherapy strategies including anti-GD2 antibodies. He co-leads national neuroblastoma consortia driving precision therapy.

Share:

🧪Research Fields 研究领域

neuroblastoma genomics
MYCN amplification
ALK inhibitors pediatric
GD2 immunotherapy
high-risk neuroblastoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 John Maris 的研究动态

Follow John Maris's research updates

留下邮箱,当我们发布与 John Maris(Children's Hospital of Philadelphia)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment